Clinical trial
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary…
NCT00004497 · United Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00004497 |
|---|---|
| Title | Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension |
| Lead sponsor | United Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | UT-15 |
| Start date | Oct 1, 1998 |
| Completion | Sep 1, 2000 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: